Government Affairs
Refine Search
Biotechnology
Canada’s federal budget for 2017 has been welcomed by a biotech trade group for supporting the advancement of the industry. 23 March 2017
Pharmaceutical
The application of cost-effectiveness criteria is a hallmark of the UK’s approach to health technology assessment, differentiating it from many other European countries. It’s an approach which raises ethical considerations around access to medical technology; which drugs we should fund and which diseases, which patients, we should treat. 22 March 2017
Pharmaceutical
The Russian Federal Antimonopoly Service (FAS) is discussing with the government lifting of the "third extra" rule for public procurement of drugs, according to recent statements of Igor Artemyev, head of the FAS, reports The Pharma Letter’s local correspondent. 22 March 2017
Pharmaceutical
Among the political news last week, perhaps the most controversial of which was US President Donald Trump’s budget blueprint – a wish list of spending priorities for legislators to consider, which included a proposal to double the use fee charge that drugmakers pay to get their products through the regulatory process and a much criticized 20% cut in the budget for the National Institutes of Health. 19 March 2017
Pharmaceutical
US President Donald Trump has released a budget ‘blueprint’ for 2018 that could have a major impact on the pharmaceutical and healthcare industries in America. 17 March 2017
Pharmaceutical
The UK’s National Institute for Health and Clinical Excellence (NICE), in collaboration with NHS England, has decided to propose a dynamic upper-limit for costs per quality adjusted life year (QALY) above which they will not recommend funding for highly specialized technologies (HST) treatments. 15 March 2017
Pharmaceutical
With proposals being discussed for a replacement of the Affordable Care Act (ACA) – or Obamacare – Kent Holtorf, the medical director for The Holtorf Medical Group, and outspoken critic of the ACA, puts forward his model for change in an expert view piece. 15 March 2017
Pharmaceutical
US Health and Human Services Secretary Dr Tom Price is questioning the findings of the Congressional Budget Office (CBO) report on the American Health Care Act, which predicts that 24 million more Americans would be uninsured by 2026 under the House Republican health care bill than under Obamacare, including 14 million by next year. 15 March 2017
Biotechnology
Australian trade group AusBiotech has waited a decade for regulatory reforms to reduce costs and administrative burden for the industry, but it is not giving up the push to see them implemented as quickly as possible. 9 March 2017
Pharmaceutical
House committees in the US capital plan to begin voting on the replacement of the Affordable Care Act (ACA) on Wednesday. 8 March 2017
Pharmaceutical
The Russian government is ready to allow the production of anti-HIV drugs bypassing patents of their right-holders, reports The Pharma Letter’s local correspondent. 8 March 2017
Pharmaceutical
The average productivity of life sciences employees in the UK, expressed as Gross Value Added (GVA), is £104,000 ($128,000), compared to the GVA average of £49,000, according to a new report. 6 March 2017
Pharmaceutical
Trade group Medicines Australia does not accept the findings of the latest Grattan Institute report on medicine prices, calling it “inaccurate, selective and misleading.” 6 March 2017
Pharmaceutical
The introduction in the USA of legislation to encourage the importation of cheaper prescription drugs from Canada and elsewhere could have serious impact on drugmakers. Last week also saw focus on the decline of the hepatitis C market as a result of the success of new drugs to treat the condition. Additionally, there was excitement around potential new drugs from La Jolla, Kite Pharma and Chi-Med. 5 March 2017
Pharmaceutical
Tuesday night, President Donald Trump gave his joint address to the nation. In it, he suggested that the US Food and Drug Administration prevents a host of new medications and medical devices from hitting the market. 2 March 2017
Pharmaceutical
US Senators Cory Booker (Democrat, New Jersey), Bernie Sanders (Independent, Vermont) and Bob Casey (Dem, Pennsylvania) introduced legislation Tuesday to lower the skyrocketing cost of prescription drugs by allowing Americans to import safe, low-cost medicine from Canada. 1 March 2017
Biotechnology
Health plans partnering with Express Scripts are delivering high-quality, affordable pharmacy care to millions of individuals enrolled in government-sponsored programs, but this record is at risk without decisive action to advance additional pro-patient and pro-payer policy changes, according to new research. 1 March 2017
Pharmaceutical
At a press conference held last week, the Hellenic Association of Pharmaceutical Companies (SFEE) issued an ultimate distress call and a strong warning against the irreparable detrimental consequences for Greek patients from the imminent Ministry of Health measures. 27 February 2017
Pharmaceutical
The mixed messages on drug pricing policy coming from new US President Donald Trump’s administration are starting to harm healthcare stocks, according to an analyst at the independent broker finnCap. 24 February 2017
Pharmaceutical
The chief executive of German pharma major Bayer (BAYN: DE) did not hold back in expressing his views on the year’s politics developments as he presented his company’s annual results for the first time. 23 February 2017
Pharmaceutical
The nomination of Robert F Kennedy Jr — known as RFK Jr — for the role of US Secretary of the Department of Health and Human Services (HHS) President-elect Donald Trump sent shares in vaccine companies sharply downwards. 22 November 2024
article
The UK government has reappointed BioIndustry Association (BIA) chairman Daniel Mahony as its Life Sciences Investment Envoy. 21 November 2024
Pharmaceutical
The Danish government’s newly-unveiled health reform has been praised for tackling chronic disease care and health inequalities while driving health innovation. 18 November 2024
Pharmaceutical
New research published by the European Federation of Pharmaceutical Industries and Associations (EFPIA) provides in-depth analysis of the economic footprint of the pharmaceutical industry in Europe, across member states and compares Europe to other regions of the world. 18 November 2024
Pharmaceutical
Johnson & Johnson has taken legal action to defend a contentious rebate initiative, filing a lawsuit in the US District Court for the District of Columbia. 15 November 2024
Pharmaceutical
The share prices of Pfizer, GSK, Novavax and other vaccine companies were all markedly lower on Friday. This was not due to the publication of disappointing research results in the sphere, or an ominous stance taken by a major regulator on a key filing, but rather a political development that could spell trouble for the vaccines field as a whole. 15 November 2024
Biotechnology
BeiGene has announced plans to rebrand as BeOne Medicines, a move the cancer specialist says reflects its commitment to fighting cancer through collaboration. 15 November 2024
Pharmaceutical
Danish patients are being offered fewer innovative treatments than Norwegians and Swedes, a new estimate from the Danish Medicines Council shows. 11 November 2024
Pharmaceutical
According to the Swedish pharma trade group Lif, it is positive that, in the updated life science strategy, the government expresses an ambition for Sweden to become more attractive for research investments. 11 November 2024
Pharmaceutical
Li Li, Commissioner of China's National Medical Products Administration (NMPA), and Mette Aaboe Hansen, interim director general of Danish Medicines Agency, have signed a letter of intent to promote bilateral cooperation in regulation of drugs and medical devices. 11 November 2024
Pharmaceutical
Following the news that Donald Trump is the winner of the 2024 US Presidential Election, Morningstar Equity analyst Julie Utterback has published a new note about the impact of this on the managed-care industry. 7 November 2024
Pharmaceutical
UK pharma major AstraZeneca, which has invested heavily in China, hosted a sell-side analyst call on Wednesday (November 6) to discuss the recent media reports about ongoing investigations in China. 7 November 2024
Pharmaceutical
Some of the UK’s leading academics and industry professionals have welcomed Chancellor Rachel Reeves’ £520 million ($669 million) pledge to develop the country’s medicine manufacturing capabilities. 6 November 2024
Pharmaceutical
European regulators will decide by December 6 whether Novo Holdings, the controlling shareholder of Danish pharma giant Novo Nordisk, can finalize its $16.5 billion acquisition of contract drug manufacturer Catalent. 5 November 2024
Pharmaceutical
The Danish government is rolling out the red carpet and welcomes several pharmaceutical companies. 4 November 2024
Generics
Medicines for Europe has launched a study of market barriers faced by European generics and biosimilar pharmaceutical companies operating in 11 key third-country markets. 31 October 2024
Pharmaceutical
Following the first Labour budget for 14 years, the Association of the British Pharmaceutical Industry (ABPI) welcomes Chancellor Rachel Reeves’ measures to improve UK life sciences competitiveness. 30 October 2024
Pharmaceutical
HOPO Therapeutics has been awarded a contract valued at up to $226 million from the Biomedical Advanced Research and Development Authority (BARDA). 29 October 2024
Pharmaceutical
The Danish government has presented part of the plan for a future life science strategy, which has been welcomed by the industry. 28 October 2024
Biotechnology
Legend Biotech has removed Genscript Biotech as its majority shareholder, in a move coinciding with rising US concerns over Chinese ties within the biotech sector. 24 October 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze